Snipd home pageGet the app
public
a16z Live chevron_right

a16z Bio + Health #2: Digital Diagnostics with Gaurav Singal

Feb 26, 2021
42:38
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
1
Introduction
00:00 • 3min
chevron_right
2
What Are Digital Diagnostics?
02:43 • 3min
chevron_right
3
Is There a Regulating Pathway for Digital Diagnostics?
05:26 • 3min
chevron_right
4
Do You Think We're Entering a Golden Age Prodigital Diagnostics?
08:47 • 3min
chevron_right
5
Is There a Digital Diagnostic Landscape?
11:34 • 2min
chevron_right
6
Is Farma a Good Idea?
13:16 • 5min
chevron_right
7
Is Bioparma a Gate Keeper of the Diagnostics Industry?
18:07 • 2min
chevron_right
8
Is There a Difference Between a Check Pan Inhibitor and a Diagnostic?
19:53 • 5min
chevron_right
9
The Development Costs of a Diagnostic Test
24:29 • 3min
chevron_right
10
Compane Diagnostics
27:53 • 4min
chevron_right
11
Digital Health and Value Based Reimbursement
31:32 • 4min
chevron_right
12
Is There a Way to Reduce the Cost of Care?
35:16 • 2min
chevron_right
13
Isa Medical Device Guidance Is Not Final Yet?
37:23 • 5min
chevron_right
On this episode of the new a16z Bio Clubhouse Show "It's Time to Heal", a16z general partners Vineeta Agarwala, Jorge Conde, Vijay Pande, talk to guest Dr. Gaurav Singal about the future of digital diagnostics: what are they, who stands to benefit from them, and critically, who pays.
HomeTop podcastsPopular guests